RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with

Xin-Zi Chi1, Jeung-Ook Yang, Kwang-Youl Lee

  • 1Department of Biochemistry, School of Medicine, and Institute for Tumor Research, Chungbuk National University, Cheongju 361-763, South Korea.

Insights

RUNX3 acts as a tumor suppressor in gastric cancer by inducing p21 expression. This transcription factor cooperates with SMADs to activate the p21 promoter, crucial for cell growth arrest.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • RUNX3 is implicated as a tumor suppressor in gastric cancer.
  • RUNX3 deficiency leads to gastric hyperplasia, increased proliferation, and reduced apoptosis.
  • Transforming growth factor beta1 (TGF-beta1) pathway, involving p21(WAF1/Cip1) induction, is a known tumor suppressor pathway.

Purpose of the Study:

  • To identify the lineage-specific transcription factor cooperating with SMADs to induce p21 expression.
  • To elucidate the role of RUNX3 in TGF-beta1-mediated p21 induction in gastric epithelial cells.

Main Methods:

  • Analysis of Runx3-null mouse gastric mucosa.
  • Overexpression studies of RUNX3.
  • Reporter assays to assess p21 promoter activity.
  • Co-expression analysis of RUNX3 and p21 in mouse and human gastric epithelium.

Main Results:

  • RUNX3 is essential for TGF-beta-dependent p21 expression in stomach cells.
  • RUNX3 overexpression enhances endogenous p21 induction.
  • RUNX3 and SMADs synergistically activate the p21 promoter.
  • A patient-derived RUNX3 mutation (R122C) impairs p21 promoter activation.
  • RUNX3 and p21 expression patterns overlap in gastric epithelium.

Conclusions:

  • RUNX3 is a key regulator of TGF-beta-induced p21 expression in gastric epithelial cells.
  • RUNX3's tumor suppressor function is partly mediated by its ability to induce p21.
  • RUNX3 acts in concert with SMADs to suppress gastric tumor development.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...